World Tuberculosis (TB) Day, observed annually on March 24, amplifies the urgency of ending tuberculosis, the world’s deadliest infectious disease. TB continues to devastate millions globally, inflicting severe health, social, and economic consequences. The WHO's key messages this year are Commit, Invest, Deliver. Proven WHO-recommended interventions include early detection, diagnosis, preventive treatment, and high-quality TB care, particularly for drug-resistant TB.
DiagCor Life Science offers multiple options for TB testing. The GenoScreenTM TB qPCR Kit is a sensitive, highly specific kit, compatible with various real time PCR machines to quickly detect Mycobacterium Tuberculosis (MTB) complex in clinical specimens. For antibiotic-resistant MTB, the GenoFlowTM DR-MTB Array Test Kit detects and genotypes tuberculosis variants resistant to rifampicin (RIF) and isoniazid (INH) in liquefied, decontaminated human respiratory specimens.
Please get in touch to learn more.
About DiagCor
Headquartered in Hong Kong with ISO 13485 accredited Quality Management System, DiagCor has been dedicated solely to molecular diagnostics (MDx) since 2006. The global leader in flow-through hybridization technology, the company offers a range of products, solutions and services related to RNA and DNA analysis. As well as providing MDx laboratory services to Asia Pacific practitioners, DiagCor develops and manufactures MDx products and solutions, and offers MDx medical translation services and MDx consulting.
Press Contact
DiagCor Life Science